PMID: 8949718Aug 1, 1996Paper

Retinopathy of prematurity in infants of birth weight > 2000 g after haemorrhagic shock at birth

The British Journal of Ophthalmology
C JandeckM H Foerster

Abstract

The risk of retinopathy of prematurity (ROP) is associated with low birth weight and low gestational age. For ROP screening examination is recommended in infants weighing < or = 1500 g or of less than 32 weeks' gestational age. From 1991 ROP screening was performed in 452 premature infants with either a birth weight < or = 1500 g (n = 303) or a birth weight > 1500 g (n = 149) and who required additional oxygen supplementation or underwent surgery with general anaesthesia before estimated term. Unexpectedly, three infants with birth weights between 2080 and 2325 g and a gestational age of 32 or 33 weeks developed stage 2 or 3 ROP. One of these underwent cryocoagulation. In three infants, preterm birth was induced by sudden placental abruption with severe prenatal blood loss followed by haemorrhagic shock. The umbilical cord packed cell volume was reduced to 0.14-0.19 (normal 0.43-0.63). All three infants underwent surgery with general anaesthesia within the first weeks of life. Of the remaining 449 infants none with a birth weight > 1650 g developed any stage of ROP. Severe prenatal blood loss requiring blood transfusions and surgery with general anaesthesia may induce higher stages of ROP even in infants with birth weights exce...Continue Reading

References

Jan 1, 1975·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·R J Brockhurst, M I Chishti
Jul 1, 1975·American Journal of Ophthalmology·M F KrausharC G Sia
Jun 1, 1992·Nature Genetics·W BergerM Warburg
May 1, 1992·The British Journal of Ophthalmology·G E QuinnS Abbasi
Jul 1, 1992·Archives of Disease in Childhood·A R Fielder, M I Levene
Aug 15, 1992·American Journal of Ophthalmology·D A PlagerB S Shastry
Jan 1, 1992·Archives of Ophthalmology·M B LandersL S Morse
Feb 15, 1991·Biological Psychiatry·A L StollI Hanin
May 1, 1991·Ophthalmology·J A McNamaraJ L Federman
Nov 26, 1988·Lancet·Y K NgM I Levene
Dec 1, 1987·Pediatric Clinics of North America·J T Flynn
Jul 15, 1986·American Journal of Ophthalmology·M E HammerK L Jackson
Apr 1, 1986·The British Journal of Ophthalmology·N W Hindle
May 1, 1974·The British Journal of Ophthalmology·F H Stefani, H Ehalt
Feb 1, 1984·American Journal of Ophthalmology·B J Kushner, E Gloeckner
Oct 1, 1980·American Journal of Ophthalmology·J SchulmanH Schwartz
Nov 20, 1993·BMJ : British Medical Journal·J L Sullivan
Feb 1, 1994·Archives of Ophthalmology·E A Palmer, R J Hardy
Sep 1, 1993·The British Journal of Ophthalmology·M Goggin, M O'Keefe
Oct 1, 1993·European Journal of Pediatrics·R W CookeA M Weindling
Aug 1, 1993·Human Molecular Genetics·Y RaviaB Goldman
Mar 1, 1993·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Y SaitoT Takeuchi

❮ Previous
Next ❯

Citations

Oct 2, 2008·Journal of Pediatric Ophthalmology and Strabismus·Fatih Mehmet MutluFaruk Alpay
Apr 3, 2016·Pediatrics International : Official Journal of the Japan Pediatric Society·Sook Kyung YumIn Kyung Sung
Apr 25, 2007·Journal of Perinatology : Official Journal of the California Perinatal Association·K MandalD I Clark
Jul 22, 2005·Clinical & Experimental Ophthalmology·Rohan W EssexJames E Elder
Oct 28, 1999·Current Opinion in Ophthalmology·R Clemett, B Darlow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.